SCHEMBL22737005

SCHEMBL22737005

N#Cc1cccc(C#N)c1-c1ccc2c(c1)c1ccccc1n2-c1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
IMPDH2 P12268 1/20 0.37
NR3C1 P04150 1/20 0.36
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
HDAC4 P56524 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
GRIA1 P42261 1/20 0.35
CACNG8 Q8WXS5 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22737183 0.96 KDM4E (0.45) KDM4EATML3MBTL1IMPDH2ALDH1A1
SCHEMBL22737403 0.96 L3MBTL1 (0.51) KDM4EATML3MBTL1IMPDH2ALDH1A1
SCHEMBL22737285 0.95 KDM4E (0.47) KDM4EATML3MBTL1IMPDH2NR3C1
SCHEMBL22737965 0.95 KDM4E (0.40) KDM4EATML3MBTL1IMPDH2
SCHEMBL22737221 0.95 KDM4E (0.47) KDM4EATML3MBTL1IMPDH2NR3C1
SCHEMBL17955102 0.94 KDM4E (0.42) KDM4EATML3MBTL1IMPDH2NR3C1
SCHEMBL22737661 0.93 KDM4E (0.43) KDM4EATML3MBTL1IMPDH2NR3C1
SCHEMBL22737296 0.93 KDM4E (0.43) KDM4EATML3MBTL1IMPDH2NR3C1
SCHEMBL22737097 0.93 KDM4E (0.43) KDM4EATML3MBTL1IMPDH2NR3C1
SCHEMBL17955105 0.92 KDM4E (0.48) KDM4EATML3MBTL1IMPDH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE CCNE2, CRY2, PER2 KDM4E 3559/4885ATM 1504/4885L3MBTL1 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.